KeyBanc raised the firm’s price target on Simulations Plus (SLP) to $37 from $35 and keeps an Overweight rating on the shares. The firm notes shares are trading at 6-times FY25 EV/Street revenues, which is toward the lower end of its digital biology peers’ valuations, particularly since it expects high-teens revenue growth over the next several years, with adjusted EBITDA margins of 35%-plus. Also, Simulations Plus’s next twelve months revenue multiple is well below its IPO levels of about 20-turns in early 2021 and well below its next twelve months adjusted EBITDA levels of 65-turns, KeyBanc adds.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLP: